MedTrace Logo

Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement

NCT04489914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2021-08-18

No results posted yet for this study

Summary

Percutaneous catheter-assisted valve replacement in aortic position (TAVI) for patients with high perioperative risk has become a standard method in recent years. In addition to the detection of bleeding and cardiac rhythm complications, follow-up care is mainly focused on the monitoring of respiratory parameters after an operation under intubation anesthesia or deep analgosedation. In addition to normal oxygen therapy, non-invasive ventilation and, in case of weaning failure, renewed tracheal intubation in the first 24 h after TAVI have been considered. High flow oxygen therapy (HFOT) now provides a good opportunity to treat patients with a warmed and humidified air-oxygen mixture and to independently control the oxygen content in the inhaled air and the flow in the pharyngeal area.

The aim of the Study is to investigate the Change in oxygenation after high-flow oxygen therapy as a measure of weaning success in postinterventional patients after TAVI.

Conditions

  • Transcatheter Aortic Valve Replacement

Interventions

DEVICE

High-Flow Oxygen Therapy

high-flow oxygen therapy after percutaneous transfemoral aortic valve replacement

Sponsors & Collaborators

  • Drägerwerk AG & Co. KGaA

    lead INDUSTRY

Principal Investigators

  • Tobias Graf, Dr · University Hospital Schleswig-Holstein

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-12
Primary Completion
2021-04-23
Completion
2021-04-23

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04489914 on ClinicalTrials.gov